Synchronous presentation of pH+ B cell acute lymphoblastic leukemia and chronic lymphocytic leukemia treated with blinatumomab
Christina Darwish, Don A Baldwin, Peter Abdelmessieh · 2026
Read Synchronous presentation of pH+ B cell acute lymphoblastic leukemia and chronic lymphocytic leukemia treated with blinatumomab by Christina Darwish, Don A Baldwin, Peter Abdelmessieh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13312526.txt.
Description
Christina Darwish and colleagues report a 2026 case of a patient diagnosed with two B-cell cancers at the same time: Philadelphia chromosome-positive acute lymphoblastic leukemia and chronic lymphocytic leukemia. Blinatumomab, a bispecific T-cell engager aimed at CD19, is approved for the acute leukemia but had barely been explored as treatment for the chronic one.
Given as consolidation therapy for the acute disease, the drug cleared the patient's measurable residual disease. Follow-up checks showed the chronic leukemia clone had been eradicated as well, leaving both diseases in deep remission. The authors note the acute leukemia masked whether the chronic clone would ever have needed treatment on its own. They present the case as evidence that CD19-directed immune therapy can reach across both conditions when they collide in one patient.
Catalog record
| CREATOR | Christina Darwish, Don A Baldwin, Peter Abdelmessieh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13525 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |